Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/jbmr.3536 | DOI Listing |
Dent Mater
February 2023
Dental Research Institute, Faculty of Dentistry, University of Toronto, Toronto, ON, Canada. Electronic address:
Objective: To evaluated the Odanacatib inhibitor treatment on lipopolysaccharide (LPS) contamination effect on cathepsin-K mediated dentin degradation by analysis of type I collagen C- and N-termini telopeptides.
Methods: Pulverized and disks of human dentin were demineralized and LPS contaminated, or stored in deionized water (DW) for 12 h. Samples were challenged with lactic acid (LA).
J Mech Behav Biomed Mater
September 2020
Dental Research Institute, Faculty of Dentistry, University of Toronto, 124 Edward St, Toronto, ON, M5G 1G6, Canada. Electronic address:
Objective: To evaluate protease activity of dentin matrices subjected to treatment with non-specific (chlorhexidine - CHX), cysteine cathepsin specific (E-64), and cysteine cathepsin-K (CT-K) specific (Odanacatib - ODN) inhibitors.
Methods: Pulverized dentin powder obtained from human dentin disks (0.5 mm thickness) completely demineralized with 10% HPO were challenged in 1 mL lactic acid (LA) (0.
Oral Surg Oral Med Oral Pathol Oral Radiol
September 2018
Department of Pediatric Dentistry, School of Dentistry of Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP, Brazil.
Objective: The aim of this study was to evaluate bone mineral density (BMD) and microarchitecture in femurs and maxillary bones of ovariectomized (OVX) rats treated or not treated with alendronate (ALD) or odanacatib (ODN).
Study Design: Twenty rats were divided into groups: SHAM, OVX, OVX/ALD, and OVX/ODN. After 12 weeks, the femurs and maxillae were removed and subjected to 3-dimensional analysis by micro-computed tomography.
J Bone Miner Res
March 2016
Division of Endocrinology and Centre for Research in Anabolic Skeletal Targets in Health and Illness (ASTHI), CSIR-Central Drug Research Institute, Lucknow, India.
Cathepsin K (CK), a lysosomal cysteine protease, is highly expressed in mature osteoclasts and degrades type 1 collagen. Odanacatib (ODN) is a selective and reversible CK inhibitor that inhibits bone loss in preclinical and clinical studies. Although an antiresorptive, ODN does not suppress bone formation, which led us to hypothesize that ODN may display restorative effect on the osteopenic bones.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!